Filter announcements
Loading...
Sandu Pharmaceuticals Ltd manufactures and trades Ayurvedic proprietary medicines.Product Portfolio: Company manufactures over 100 types of products, including oils, syrups, granules, powder, and avlehas, which are marketed under the Sandu brand viz, Sandu Ashoka Compound, Sandu Abhayarishta, Sandu Arvindasav, Sandu Balant Kadha No. 1, Sandu Debix Tablet, Sandu Bhunimbadi Kadha,...
Sandu Pharmaceuticals has resolved a GST matter concerning an input tax credit claim initially amounting to Rs. 52.14 Lakh. Following the company's detailed reconciliation, the Maharashtra GST Department largely accepted their claim. The company paid a minor sum of Rs. 2.22 Lakh for the disallowed portion and an additional Rs....
Sandu Pharmaceuticals has secured a refund order from the Goa Commercial Taxes Department. The company received approximately 0.029 Cr as a Value Added Tax (VAT) refund for the fiscal year 2014-15. This positive development means a direct cash inflow, settling a specific past tax liability. While the amount is modest,...
Sandu Pharmaceuticals has submitted a certificate from MUFG Intime India Pvt. Ltd., its Registrar and Share Transfer Agent, confirming that all securities received for dematerialisation during the quarter were processed—either accepted or rejected—and appropriately updated in the shareholder register. The dematerialised securities remain listed on the existing stock exchanges. Physical...
Sandu Pharmaceuticals has responded to a show cause notice from the Maharashtra GST Department regarding excess input tax credit of Rs. 96.48 lakh, including interest and penalty, related to discrepancies in GST filings. The company clarified that the delay in informing the exchange about the notice was unintentional and due...
Sandu Pharmaceuticals has received a show cause notice from the Maharashtra GST Department for alleged excess input tax credit claimed amounting to Rs. 96.48 lakh, including interest and penalty. The issues relate to discrepancies in ITC claims and liability reconciliation. The company plans to respond to the notice and, based...